Dorte A. Larsen

Palle Juul Jensens Boulevard 167
Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Correction: Hansen et al. Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial. J. Pers. Med. 2024, 14, 175.

Correction: Hansen et al. Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial. J. Pers. Med. 2024, 14, 175.

Journal: Journal of personalized medicine

Published: December 01, 2025

3-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial.

3-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial.

Journal: The British journal of ophthalmology

Published: November 26, 2024

Comparing glaucoma risk in children receiving low-dose and high-dose glucocorticoid treatment after cataract surgery.

Comparing glaucoma risk in children receiving low-dose and high-dose glucocorticoid treatment after cataract surgery.

Journal: Acta ophthalmologica

Published: May 07, 2024

Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial.

Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial.

Journal: Journal of personalized medicine

Published: January 06, 2024

School performances in children with cataract: results from a population-based cohort study.

School performances in children with cataract: results from a population-based cohort study.

Journal: BMJ open

Published: August 02, 2023

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.

Journal: BMC ophthalmology

Published: June 19, 2023

Prevalence and risk factors for hypothalamus-pituitary-adrenal axis suppression in infants receiving glucocorticoid eye drops after ocular surgery.

Prevalence and risk factors for hypothalamus-pituitary-adrenal axis suppression in infants receiving glucocorticoid eye drops after ocular surgery.

Journal: Acta ophthalmologica

Published: May 23, 2022

Prevalence of allergic sensitization with vernal keratoconjunctivitis: A systematic review with meta-analyses.

Prevalence of allergic sensitization with vernal keratoconjunctivitis: A systematic review with meta-analyses.

Journal: Acta ophthalmologica

Published: March 31, 2022

Ocular morbidity in Marfan syndrome: a nationwide epidemiological study.

Ocular morbidity in Marfan syndrome: a nationwide epidemiological study.

Journal: The British journal of ophthalmology

Published: December 06, 2021

TUBB3 Arg262His causes a recognizable syndrome including CFEOM3, facial palsy, joint contractures, and early-onset peripheral neuropathy.

TUBB3 Arg262His causes a recognizable syndrome including CFEOM3, facial palsy, joint contractures, and early-onset peripheral neuropathy.

Journal: Human genetics

Published: August 06, 2021

Increased Incidence of Mental Disorders in Children with Cataract: Findings from a Population-based Study.

Increased Incidence of Mental Disorders in Children with Cataract: Findings from a Population-based Study.

Journal: American journal of ophthalmology

Published: June 26, 2021

Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.

Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.

Journal: Orphanet journal of rare diseases

Published: April 27, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026